Aspirin for primary prevention of atherosclerotic cardiovascular events.
Where this comes from
- Record sourced from PubMed, PMID 32357985.
- Also identified by DOI 10.3949/ccjm.87a.19045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent trials evaluated the impact of aspirin for primary prevention of cardiovascular events in patients at intermediate risk, patients with diabetes, and the elderly, and the results have been incorporated into the most recent professional guidelines. For the most part, the role of aspirin in primary prevention remains limited, albeit not adequately tested in those at higher risk.
Medical subject headings
- Aspirin
- Atherosclerosis
- Cardiovascular Diseases